|
|
See Category: Diseases of the eye and adnexa
See Header: Degenerative myopia with choroidal neovascularization
ICD-10 (CM) Code and Descriptor
|
H44.2A1 |
Degenerative myopia with choroidal neovascularization, right eye
|
H442A1 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
ICD10
Position 17 |
| 61.20%
|
18.75%
|
10.68%
|
3.91%
|
2.34%
|
1.04%
|
0.52%
|
0.78%
|
0.26%
|
0.26%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H44.2A1*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
92134
|
CPTRZ OPH DX IMG PST SGM RTA |
142
|
142
|
|
67028
|
INJECTION EYE DRUG |
103
|
103
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
94
|
94
|
|
C9257
|
BEVACIZUMAB INJECTION |
70
|
334
|
|
J2778
|
RANIBIZUMAB INJECTION |
17
|
85
|
|
92014
|
COMPRE OPH EXAM EST PT 1/> |
17
|
17
|
|
J0178
|
AFLIBERCEPT INJECTION |
14
|
27
|
|
92250
|
FUNDUS PHOTOGRAPHY W/I&R |
9
|
9
|
|
92012
|
INTRM OPH EXAM EST PATIENT |
6
|
6
|
|
92201
|
OPSCPY EXTND RTA DRAW UNI/BI |
6
|
6
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
5
|
5
|
|
92202
|
OPSCPY EXTND ON/MAC DRAW |
4
|
4
|
|
J9035
|
BEVACIZUMAB INJECTION |
4
|
5
|
|
J7999
|
COMPOUNDED DRUG, NOC |
3
|
3
|
|
92235
|
FLUORESCEIN ANGRPH MLTIFRAME |
3
|
3
|
|
92133
|
CPTRZD OPH DX IMG PST SGM ON |
2
|
2
|
|
76510
|
OPH US DX B-SCAN&QUAN A-SCAN |
2
|
2
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
2
|
2
|
|
J3396
|
VERTEPORFIN INJECTION |
2
|
150
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
2
|
56
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H44.2A1 related to the following DRG Codes:
124-125
|
